Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell mediated immunity (CMI), also known as cellular immunity, is a branch of the adaptive immune response that does not involve antibodies. Instead, it relies on the activation of specific immune cells—primarily T lymphocytes (T cells), macrophages, and natural killer (NK) cells—to identify and eliminate infected or abnormal host cells. CMI is especially important for defending against intracellular pathogens such as viruses, certain bacteria and fungi, as well as cancerous or transformed cells. Key components include T lymphocytes (Cytotoxic T cells, Helper T cells, Memory T cells), Antigen Presenting Cells (APCs), and Macrophages & NK Cells. The mechanism involves antigen presentation, T cell activation, and effector functions, leading to the elimination of infected or cancerous cells.
Not applicable - CMI is a complex immune process, not a single druggable target with a specific mechanism of action.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Mediated Immunity Response (CMI).